Pharmacokinetics and Pharmacodynamics Practice Questions

Q: In competitive antagonism, what happens to the Vmax?

Vmax remains the same. In **competitive antagonism**, the antagonist binds reversibly to the same active site as the agonist. Because they compete for the same receptor, the outcome depends on the relative concentrations of the two molecules. ### Why the correct answer is right: * **Vmax (Efficacy) remains the same:** If you increase the concentration of the agonist sufficiently, it can "outcompete" and displace the antagonist from the receptors. Therefore, the maximal response (Vmax or Emax) can still be achieved, provided enough agonist is present. On a graph, this is represented by a **parallel rightward shift** of the dose-response curve. ### Why the incorrect options are wrong: * **Potency remains the same:** This is incorrect. Because more agonist is required to achieve the same effect in the presence of an antagonist, the **EC50 increases**, meaning the **potency decreases**. * **Km decreases:** In enzyme kinetics (analogous to receptor binding), competitive inhibition **increases the Km** (Michaelis constant). A higher Km indicates a decreased affinity of the enzyme/receptor for the substrate/agonist. * **Efficacy decreases:** This is a characteristic of **non-competitive antagonism**, where the antagonist binds to an allosteric site or binds irreversibly, preventing the agonist from reaching Vmax regardless of the dose. ### High-Yield Clinical Pearls for NEET-PG: * **Competitive Antagonism:** Parallel rightward shift, Vmax constant, Km/EC50 increases. (Example: Atropine vs. Acetylcholine). * **Non-Competitive Antagonism:** Downward shift, Vmax decreases, Km/EC50 remains constant. (Example: Phenoxybenzamine at alpha receptors). * **Key Distinction:** Competitive antagonism can be overcome by increasing agonist concentration; non-competitive cannot.

Q: Which route of administration will produce the least onset of action?

Application to a bronchotracheal mucous membrane. ### Explanation The speed of onset of action for any drug is primarily determined by the **vascularity** of the site of administration and the **surface area** available for absorption. **Why Option C is Correct:** The **bronchotracheal mucous membrane** has a relatively smaller surface area and lower vascular density compared to the alveolar surface or direct intravenous access. While absorption through mucous membranes is generally faster than the oral route, it is significantly slower than the other options provided. Therefore, among the choices, it produces the **least (slowest) onset of action.** **Analysis of Incorrect Options:** * **D. Injection into blood vessels (Intravenous):** This provides the **fastest** onset of action because it bypasses the absorption phase entirely, achieving immediate 100% bioavailability. * **B. Inhalation of gaseous form:** This involves the **alveolar membrane**, which has a massive surface area (approx. 70-100 $m^2$) and an extremely rich capillary network. This results in an onset of action almost as rapid as an IV injection (e.g., volatile anesthetics). * **A. Application to a serous surface:** Serous membranes (like the peritoneum) have a very large surface area and high vascularity, leading to very rapid absorption, often faster than mucous membrane application. **NEET-PG High-Yield Pearls:** * **Order of Onset Speed:** IV > Inhalation (Alveolar) > Intraperitoneal/Serous > Intramuscular > Subcutaneous > Oral. * **Bioavailability:** Defined as the fraction of an unchanged drug that reaches the systemic circulation. It is 100% (1.0) for the IV route. * **First-Pass Metabolism:** Routes that bypass the liver (IV, Sublingual, Transdermal, Inhalation) have higher systemic availability compared to the oral route.

Q: Which of the following drugs is not converted into an active metabolite?

Lisinopril. **Explanation:** The question tests the concept of **Prodrugs** and **Active Metabolites**. Most drugs are inactivated by metabolism, but some are converted into active forms to exert their therapeutic effects. **Why Lisinopril is the Correct Answer:** Lisinopril is a notable exception among ACE inhibitors. While most ACE inhibitors (like Enalapril, Ramipril, and Perindopril) are **prodrugs** that must be converted by the liver into their active "-at" forms (e.g., Enalaprilat), **Lisinopril and Captopril are already active drugs**. They do not undergo hepatic activation and are excreted unchanged by the kidneys. This makes Lisinopril a preferred choice in patients with hepatic impairment. **Analysis of Incorrect Options:** * **Cyclophosphamide:** This is a classic **prodrug**. It is inactive in vitro and must be activated by hepatic cytochrome P450 enzymes into **4-hydroxycyclophosphamide** and **aldophosphamide** to exert its cytotoxic effect. * **Diazepam:** This benzodiazepine has a very long half-life because it is converted into several **active metabolites**, including **nordiazepam** (desmethyldiazepam) and **oxazepam**, which prolong its sedative effects. * **Fluoxetine:** This SSRI is metabolized into **norfluoxetine**, an active metabolite with an even longer half-life (7–15 days) than the parent drug, contributing to its sustained clinical effect. **NEET-PG High-Yield Pearls:** * **ACE Inhibitor Rule:** All ACE inhibitors are prodrugs **EXCEPT** Captopril and Lisinopril. * **Active Metabolite of Morphine:** Morphine-6-glucuronide (more potent than morphine). * **Prodrug of Epinephrine:** Dipivefrine (used in glaucoma). * **Prodrug of Dopamine:** Levodopa (crosses the blood-brain barrier).

Q: What is Hoffmann's elimination?

Inactivation of a drug by molecular rearrangement.. ### **Explanation** **Hoffmann's elimination** is a unique pharmacokinetic process where a drug undergoes spontaneous non-enzymatic degradation in the plasma and tissues. **1. Why Option D is Correct:** The correct answer is **inactivation of a drug by molecular rearrangement**. Unlike most drugs that require hepatic enzymes or renal clearance, drugs undergoing Hoffmann's elimination break down spontaneously due to the physiological pH and temperature of the body. This is a purely chemical process (molecular rearrangement) that does not involve any biological catalysts (enzymes). **2. Why Other Options are Incorrect:** * **Option A:** This refers to **biotransformation** (metabolism), typically occurring in the liver via Cytochrome P450 enzymes. * **Option B:** This refers to **renal excretion**, the primary route for water-soluble drugs. * **Option C:** This refers to **biliary or fecal excretion**, common for large molecular weight compounds or unabsorbed oral drugs. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Prototype Drug:** The classic example is **Atracurium** (a non-depolarizing neuromuscular blocker). Its derivative, **Cisatracurium**, also undergoes this process. * **Clinical Advantage:** Because it does not rely on the liver or kidneys, Atracurium is the **muscle relaxant of choice for patients with liver or kidney failure**. * **Factors Affecting Rate:** Since it is a chemical reaction, the rate of Hoffmann's elimination is increased by **hyperthermia** and **alkalosis**, and decreased by hypothermia and acidosis. * **Metabolite Note:** A byproduct of this reaction is **laudanosine**, which can cross the blood-brain barrier and potentially cause seizures in very high concentrations (though rare clinically).

Q: Which of the following pairs of drugs are metabolized by the same Cytochrome enzyme?

Omeprazole and Clopidogrel. **Explanation:** The correct answer is **A. Omeprazole and Clopidogrel**. Both drugs are primary substrates for the isoenzyme **CYP2C19**. **1. Why Option A is Correct:** Clopidogrel is a prodrug that requires activation by the CYP2C19 enzyme to its active thiol metabolite to exert its antiplatelet effect. Omeprazole is also metabolized by (and is a potent inhibitor of) CYP2C19. This shared pathway is clinically significant because omeprazole can competitively inhibit the activation of clopidogrel, potentially leading to reduced antiplatelet efficacy and an increased risk of cardiovascular events. **2. Analysis of Incorrect Options:** * **B. Phenytoin and Tacrolimus:** Phenytoin is primarily metabolized by **CYP2C9** (and 2C19), whereas Tacrolimus is a major substrate of **CYP3A4**. * **C. Paracetamol and Warfarin:** Paracetamol is mainly metabolized via glucuronidation and sulfation (with a small portion via **CYP2E1** to NAPQI), while Warfarin (specifically the more potent S-isomer) is metabolized by **CYP2C9**. * **D. Omeprazole and Warfarin:** As noted, Omeprazole uses **CYP2C19**, while Warfarin uses **CYP2C9**. **High-Yield NEET-PG Pearls:** * **CYP3A4:** The most abundant CYP enzyme; metabolizes ~50% of all drugs (e.g., Statins, CCBs, HIV Protease inhibitors). * **CYP2D6:** Shows significant genetic polymorphism; metabolizes Codeine, Metoprolol, and Haloperidol. * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. * **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**rimethoprim, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**il (Cimetidine), **K**etoconazole.

Q: Which statement about the absorption of acidic drugs is true?

Best absorbed in acidic medium. **Explanation:** The absorption of drugs across biological membranes is primarily governed by the **pH Partition Hypothesis**. Most drugs are weak electrolytes, and their movement across lipid membranes depends on their degree of ionization. **1. Why Option A is Correct:** According to the Henderson-Hasselbalch equation, an **acidic drug** (like Aspirin or Barbiturates) remains in its **unionized (lipid-soluble) form** when placed in an **acidic medium** (low pH). Since only the unionized form can easily diffuse across the lipid bilayer of cell membranes, acidic drugs are best absorbed from the stomach or the proximal part of the duodenum where the pH is low. **2. Why Other Options are Incorrect:** * **Option B & C:** In an alkaline medium, acidic drugs become ionized (water-soluble). Ionized drugs are polar and cannot easily cross lipid membranes, leading to poor absorption. This principle is clinically utilized in "Urinary Alkalinization" to trap acidic drugs in the urine for excretion during toxicity. * **Option D:** Acidic drugs typically bind to **Plasma Albumin**. It is **basic drugs** (like Propranolol, Lidocaine, or Quinidine) that primarily bind to **Alpha-1-acid glycoprotein (AAG)**. **High-Yield NEET-PG Pearls:** * **Ion Trapping:** To treat acidic drug poisoning (e.g., Aspirin), we alkalinize the urine with Sodium Bicarbonate. This ionizes the drug in the renal tubules, preventing reabsorption and enhancing excretion. * **Binding Sites:** * **Acidic Drugs:** Bind to Albumin (Site I: Warfarin/Azapropazone; Site II: Diazepam/Ibuprofen). * **Basic Drugs:** Bind to Alpha-1-acid glycoprotein. * **Rule of Thumb:** "Like is unionized in like" (Acidic in Acidic / Basic in Basic). Only the unionized form is pharmacologically active and absorbable.

Question 1

In competitive antagonism, what happens to the Vmax?

Accepted Answer

Vmax remains the same

Answer

Potency remains the same

Answer

Km decreases

Answer

Efficacy decreases

Question 2

Which route of administration will produce the least onset of action?

Accepted Answer

Application to a bronchotracheal mucous membrane

Answer

Application to a serous surface

Answer

Inhalation of gaseous form

Answer

Injection into blood vessels

Question 3

Which of the following drugs exhibit zero-order kinetics at high doses?

Accepted Answer

Phenytoin and Propranolol

Answer

Digoxin and Propranolol

Answer

Amiloride and Probenecid

Answer

Lithium and Theophylline

Question 4

Drug excretion through the kidney depends on all EXCEPT:

Accepted Answer

Molecular weight of the drug

Answer

High blood flow in the kidney

Answer

Lipid solubility of the drug

Answer

Plasma protein binding of the drug

Question 5

Which of the following drugs is not converted into an active metabolite?

Accepted Answer

Lisinopril

Answer

Cyclophosphamide

Answer

Diazepam

Answer

Fluoxetine

Question 6

What is Hoffmann's elimination?

Accepted Answer

Inactivation of a drug by molecular rearrangement.

Answer

Inactivation of a drug by a metabolizing enzyme.

Answer

Unchanged excretion of a drug by the kidney.

Answer

Excretion of a drug in the feces.

Question 7

Which of the following pairs of drugs are metabolized by the same Cytochrome enzyme?

Accepted Answer

Omeprazole and Clopidogrel

Answer

Phenytoin and Tacrolimus

Answer

Paracetamol and Warfarin

Answer

Omeprazole and Warfarin

Question 8

Which statement about the absorption of acidic drugs is true?

Accepted Answer

Best absorbed in acidic medium

Answer

Best absorbed in alkaline medium

Answer

Not absorbed in acidic medium

Answer

Binds to alpha-1-acid glycoprotein

Question 9

Which of the following statements is true regarding the intravenous route of drug administration?

Accepted Answer

Suspensions can be administered

Answer

It is useful in emergencies

Answer

Aseptic precautions are required

Answer

Bioavailability is 100%

Question 10

A clinical pharmacologist is gathering pharmacokinetic data during clinical trials of a new antimicrobial agent. He has already determined that the half-life of this drug is 4 hours. He began a continuous intravenous drip 24 hours ago at a rate of 10 mg/min. Blood tests after 24 hours reveal that the patient's drug plasma concentration is 20 mg/L. What is the clearance of this agent?

Accepted Answer

0.5 L/min

Answer

2 L/min

Answer

10 L/min

Answer

50 L/min

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?